June 24, 2010

NASDAQ OMX (NASDAQ:NDAQ) announced that Oasmia Pharmaceutical AB (OASM), a Small Cap company within the Biotech sector, today starts trading of its shares on the main market of NASDAQ OMX Stockholm. Oasmia is the twelfth company to list on NASDAQ OMX in Europe in 2010.
 

Oasmia Pharmaceutical AB is based in Sweden and was founded in 1999. Oasmia develops a new generation of pharmaceuticals with the emphasis on human and veterinary oncology, with a vision to improve treatments of severe diseases. Learn more about Oasmia »

 

Follow Oasmia's share information »
 

	Weine Nejdemo CFO of Oasmia Pharmaceutical AB, is welcomed to NASDAQ OMX Nordic by Jenny Rosberg Senior Vice President, NASDAQ OMX.
	Annette Ljungmark, Head of Accounting and Human Resources,  tolls the bell together with Weine Nejdemo.
	Weine Nejdemo recevies a frame with the first closed deal.
	Oasmia celebrating the first day of listing at NASDAQ OMX Nordic.

Listings 2012
Listings 2011
Listings 2010
First North Corporate Actions

December 16
Avega Group

December 15
CDON Group AB

December 8
Trigon Agri

November 23
Zealand Pharma

November 14
UBS (Exchange traded funds)

November 12
Etrion

October 12
XACT Fonder

October 5
Pandora

October 25
Danske Bank warrants

June 24
Oasmia Pharmaceutical AB

June 21
Odd Molly

June 3
Chr. Hansen Holding A/S